Golden Heart Flower is an early-stage pharmaceutical company dedicated to addressing rare diseases. Their 1st indication is an ultra-rare disease called Adult Polyglucosan Body Disease (APBD), for which they are developing GHF201, a small molecule drug. GHF201 shows promise beyond APBD, potentially impacting various lysosomal storage diseases by enhancing lysosomal activity. With approval for compassionate use from the Israeli Ministry of Health, the company has gathered 5 years of clinical data from 3 APBD patients, indicating both safety and efficacy.

About The Project

Services: Communicating Value to investors, physicians and patients

Golden Heart Flower engaged with The Healthcare Stage to prepare videos and audio podcasts with which the company could initiate interaction with potential investors and strategic partners. An important additional goal was to increase awareness among the patients and the medical community to this ultra rare disease which often times is misdiagnosed. This is exceptionally important as there is a dedicated genetic test for APBD disease.

Audio Podcast

Our podcasts are crafted to amplify your message, connecting you directly with your pre-defined target audience.

Testimonial

Projects

We believe our clients are often sitting on a goldmine of content that’s ready to be told. Our expertise lies in identifying and revitalizing these assets, transforming them into high-impact materials that drive business success and key performance indicators.

Inspira technologies

see all projects

Showcasing impactful collaborations that drive innovation and success in healthcare.